Average Co-Inventor Count = 6.56
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (61 from 2,405 patents)
2. Merck + Co., Inc. (4 from 4,770 patents)
3. Elexopharm Gmbh (4 from 7 patents)
4. Merck Sharp & Dohme LLC (2 from 9 patents)
5. Nicox S.a. (1 from 106 patents)
6. Merck Canada Inc. (1 from 40 patents)
7. Nicox (1 from 1 patent)
67 patents:
1. 12497403 - Factor XIa inhibitors
2. 12492187 - Factor XI activation inhibitors
3. 12466831 - Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
4. 12428397 - Factor XI activation inhibitors
5. 12414952 - Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
6. 12344616 - Factor XIa inhibitors
7. 12304899 - Factor XI activation inhibitors
8. 12263171 - 7-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
9. 12060357 - 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
10. 11312719 - 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
11. 10822338 - Substituted aminoquinazoline compounds as Aantagonist
12. 10472347 - Aminopyrazine compounds with A2A antagonist properties
13. 10344039 - Macrocyclic spirocarbamate derivatives as factor XIa inhibitors, pharmaceutically acceptable compositions and their use
14. 10214512 - Factor XIA inhibitors
15. 10143681 - Factor XIa inhibitors